PDA

View Full Version : open access article on intermittent HIGH DOSE lapatinib with mTor/AKT inhibitor

Lani
02-19-2011, 10:59 AM
http://www.ncbi.nlm.nih.gov/pubmed?term=20371474
Unregistered
02-19-2011, 05:41 PM
To overcome the cancer cells' compensatory mechanisms, we coadministered a phosphoinositide 3-kinase-mammalian target of rapamycin inhibitor
Heh, rapamycin again, it seems to work.